How Wockhardt Chairman Habil Khorakiwala plans to pull the company out of trouble
In 2012, Wockhardt emerged out of a bruising debt-restructuring exercise, having sold its promising nutrition business to French FMCG major Danone for $356 million. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 20, 2018 Category: Pharmaceuticals Source Type: news

Indian pharma majors are rushing to ‘Make in America’
Experts said it makes sense for many Indian companies to set up manufacturing base in the US, because India's corporate tax issues have not been addressed. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 19, 2018 Category: Pharmaceuticals Source Type: news

Biocon teams up with Sandoz for next-gen Biosimilars
Biosimilars are identical copies of highly complex biologic drugs that are said to have the same efficacy. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 18, 2018 Category: Pharmaceuticals Source Type: news

Torrent Pharma buys US firm Bio-Pharm
Torrent Pharma said it plans further investments to expand the BPI facilities, including its research and development (R&D) capabilities, and increase the number of product filings from BPI. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 18, 2018 Category: Pharmaceuticals Source Type: news

Indian pharma majors rush to ‘Make in America’
Several Indian drugmakers that have large operations in the US are now pushing to acquire assets there by either investing in greenfield manufacturing facilities or through brownfield M&As. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 18, 2018 Category: Pharmaceuticals Source Type: news

Suven gets product patents in China, Sri Lanka
The two patents are valid through 2033 and 2032, respectively, the company said in a BSE filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 18, 2018 Category: Pharmaceuticals Source Type: news

Panacea Biotec partners Serum Institute for hexavalent vaccine
The vaccine is a combination of six antigens to protect against six dreaded diseases - Diphtheria, Tetanus, Pertussis, Hepatitis B, Haemophilus influenza type B and Polio. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 18, 2018 Category: Pharmaceuticals Source Type: news

NPPA fixes retail price of 30 drug formulations
The National Pharmaceutical Pricing Authority (NPPA) has also revised the prices of three formulations, including that of anti cancer drug -- Gemcitabine. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 17, 2018 Category: Pharmaceuticals Source Type: news

Dr Reddy's recalls over 1,000 vials of cancer drug from US
Health regulators raised a red flag over a defect in the sealing of Docetaxel injection vials- a drug used for treating breast cancer. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 17, 2018 Category: Pharmaceuticals Source Type: news

JB Chemicals & Pharma's Gujarat facilities get European nod
"JB Chemicals& Pharmaceuticals is pleased to announce receipt of European GMP approval for its formulation facilities at Panoli, Gujarat from Medicines Authority of Malta," JB Chemicals& Pharmaceuticals said in a BSE filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 17, 2018 Category: Pharmaceuticals Source Type: news

Piramal Enterprises explores re-entry into Indian formulations business
The company is looking at introducing respiratory and central nervous system formulations in India, the people said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 17, 2018 Category: Pharmaceuticals Source Type: news

GSK Consumer Healthcare appoints Filippo Lanzi as APAC head
Commenting on the appointment, McNamara said: "His (Lanzi) people-focused leadership style and proven track record of growing categories and transforming businesses are exactly what we need to win." (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 16, 2018 Category: Pharmaceuticals Source Type: news

Regulator weighs inspection of drug-making facilities in US
​​​​According to the proposal, the sites will be inspected if they have made substandard drugs, received quality complaints, or faced action by other regulatory authorities. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 15, 2018 Category: Pharmaceuticals Source Type: news

A $300-billion reason India's drug price cap will stay
When it comes to intellectual property, it's now understood — and grudgingly accepted — that India's use of compulsory licensing won't go away. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 15, 2018 Category: Pharmaceuticals Source Type: news

Lupin forays into OTC segment;eyes Rs 300 crore turnover in 5 years
Softovac's shift to OTC was piloted in West Bengal during which the brand witnessed a growth in sales of over 25 per cent, and post the success, a pan-India rollout was initiated. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 15, 2018 Category: Pharmaceuticals Source Type: news

India's plan to reduce medicine prices faces industry pushback
The Draft Pharmaceutical Policy has made no progress since opposition emerged from the industry and among some government agencies. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 12, 2018 Category: Pharmaceuticals Source Type: news

Intas low-balls Mallinckrodt unit bid to $1bn on legal fears
Last year, media reports mentioned that Intas had emerged as a strong contender to acquire Mallinckrodt unit in a deal estimated between $1.5-2 billion. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 11, 2018 Category: Pharmaceuticals Source Type: news

Drug regulator teaming up to re-inspect manufacturing plants of pharma cos in next three weeks
These inspections come at a time when some of the largest Indian drug makers are still struggling with compliance procedures set by global regulatory agencies like the US FDA and Health Canada. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 11, 2018 Category: Pharmaceuticals Source Type: news

Indian pharma majors weigh bids for Sanofi ’s $2 billion European generics business
The portfolio of acute, chronic and oncology products could fetch a valuation of $1.5-2 bn, making it among the largest outbound transactions pursued by an Indian drug company, said sources. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 11, 2018 Category: Pharmaceuticals Source Type: news

Eyeing over 80% sales from US, India, Europe by 2021: Glenmark
As part of its medium term strategy, the company is also looking at increasing presence in complex generics, Glenmark said in a presentation to be made at the J P Morgan Healthcare Conference in the US (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 10, 2018 Category: Pharmaceuticals Source Type: news

Domestic stent manufacturer SMT raises Rs 250 crore from Morgan Stanley PE & Samara Capital
The proceeds from the transaction will be used to finance SMT ’s strong organic growth, achieve synergistic acquisitions and build an aggressive R&D program for a further expansion of its portfolio of innovative lifesaving medical devices. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 10, 2018 Category: Pharmaceuticals Source Type: news

Hilleman Labs to partner future vaccine manufacturing hub
UK Department for Health has granted GBP 10 million funding for the hub that will be managed by the Engineering and Physical Sciences Research Council (EPSRC), it said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 9, 2018 Category: Pharmaceuticals Source Type: news

NPPA lens on five pharma companies for Hepatitis C drug overcharge
NPPA has sent show-cause notices to these companies alleging overcharging for the combination drug used to treat the potentially fatal Hepatitis C virus that harms the liver. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 8, 2018 Category: Pharmaceuticals Source Type: news

Orchid Pharma gets EIR from USFDA for its Chennai facility
As per the USFDA, after the completion of an inspection of a facility, an EIR is issued to a company detailing inspectional findings. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 8, 2018 Category: Pharmaceuticals Source Type: news

US FDA may inspect Sun Pharma ’s Halol site in February: Sources
Earlier in September 2014, the Halol site came under the lens, receiving as many as 23 observations from the US agency.The inspection culminated into a warning letter fifteen months on in December 2015. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 7, 2018 Category: Pharmaceuticals Source Type: news

Eight Chinese pharma firms may be blacklisted over quality issues
According to sources in the DCGI, the companies on the verge of getting blacklisted are currently supplying a huge chunk of raw material to the Indian drug manufacturers. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 7, 2018 Category: Pharmaceuticals Source Type: news

I ​​ndia imported APIs worth Rs 18,372.54 crore in 2016-17
APIs estimated to be worth Rs 12,254.97 crore were imported from China followed by the US at Rs 820.18 crore in 2016-17, the Minister of State for Health said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 5, 2018 Category: Pharmaceuticals Source Type: news

CCI fines Gujarat chemist association for limiting medicine supply
The commission warned that given the widespread and continuing indulgence in the Anti-competitive practices, it will be keeping a close watch on the conduct by all such entities in various parts of the country. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 5, 2018 Category: Pharmaceuticals Source Type: news

Glenmark launches biosimilar Adalimumab in India
Glenmark did not give any financial detail for the drug, but globally Adalimumab is estimated to be a $16 billion drug in 2016, making it the "best" selling drug in the world. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 4, 2018 Category: Pharmaceuticals Source Type: news

Bharat Biotech's typhoid vaccine gets WHO pre-qualification
This enables the procurement and supplies of this vaccine to UNICEF, Pan-American Health Organisation (PAHO) and GAVI-supported countries, the Hyderabad-based company said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 3, 2018 Category: Pharmaceuticals Source Type: news

USFDA issues warning letter to Fresenius Kabi for Baddi plant
The regulator also asked Fresenius Kabi AG to ensure sufficient investigation of potential vulnerabilities in the manufacturing operation and potential correlations with past incidents. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 3, 2018 Category: Pharmaceuticals Source Type: news

Dip in pharma exports due to shifting of manufacturing bases, market consolidation: Government
In 2016-17, the exports decreased by 0.43 per cent in value terms and 6.95 per cent in volume terms, Minister of State for Commerce and Industry C R Chaudhary said (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 3, 2018 Category: Pharmaceuticals Source Type: news

Indian pharma will continue to stare at single digit growth: ICRA
The aggregate revenues of ICRA ’s sample comprising 21 companies grew marginally at 0.8% in Q2FY2018 Vs the prior year as against Q1 FY2018 growth at -8.8%. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 3, 2018 Category: Pharmaceuticals Source Type: news

Hetero launches HumiraTM biosimilar in India
The product will be marketed by Hetero Healthcare under the brand name ‘MaburaTM’ in India, the company said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 3, 2018 Category: Pharmaceuticals Source Type: news

NPPA fixes retail prices of 14 formulations
Drug price regulator has also asked manufacturers to furnish quarterly return regarding production, import and sale of their products. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 2, 2018 Category: Pharmaceuticals Source Type: news

PMBJPs selling drugs up to 96% cheaper than branded equivalents
Mandaviya, in a written reply in the Lok Sabha , said that the branded generic medicines are generally sold at higher prices in comparison to their unbranded generic equivalents. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 2, 2018 Category: Pharmaceuticals Source Type: news

Apax Partners, Carlyle front-runners for Mankind Pharma stake sale
Apax Partners& Carlyle have been shortlisted and are currently the front-runners for the proposed stake sale by Mankind Pharma, said two sources. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 1, 2018 Category: Pharmaceuticals Source Type: news

Vivimed Labs gets additional $7.5 million funding from OrbiMed Asia
The company had earlier received USD 42.5 million from OrbiMed Asia in September 2017, Vivimed Labs said in a BSE filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 1, 2018 Category: Pharmaceuticals Source Type: news

Mylan-Biocon's breast cancer biosimilar gets ANVISA nod
Biosimilar trastuzumab, indicated for breast cancer treatment, has been co-developed by Biocon and Mylan. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 29, 2017 Category: Pharmaceuticals Source Type: news

Zydus Pharmaceuticals gets USFDA nod for OCD treatment drug
The company has received final approval from the US Food and Drug Administration (USFDA) to market the drug in the strength of 25 mg, 50 mg and 75 mg, Zydus Cadila said in a BSE filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 29, 2017 Category: Pharmaceuticals Source Type: news

Lupin gets USFDA nod for generic psoriasis treatment solution
The USFDA approval to Lupin's calcipotriene topical solution is for strength of 0.005 per cent (scalp solution), the company said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 28, 2017 Category: Pharmaceuticals Source Type: news

Pharma cos' revenues seen clipping at 9% over next 3 yrs
Over half of the exports are to the regulated markets in the West but those are set to de-grow by 5 per cent this fiscal, after growing 3 per cent last fiscal. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 28, 2017 Category: Pharmaceuticals Source Type: news

Lupin moves court fearing tax on pre-GST stock
​Lupin, like many other pharma companies, is worried that some of the stock lying in its godowns could face double taxation due to goods and services tax (GST) regulations. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 27, 2017 Category: Pharmaceuticals Source Type: news

Expired, damaged drugs returned are not “supplies”; to save Rs 500 crore hit
Indian Pharmaceutical Alliance had noted that the industry annually receives around Rs 3300 to Rs 5500 crore in expired or damaged stock and expected a hit of about Rs 500 crore. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 27, 2017 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma gets USFDA nod for Fondaparinux Sodium injection
The approved ANDA is a bioequivalent and therapeutically equivalent to the reference listed drug product Arixtra Injection of Mylan Ireland, said Aurobindo Pharma. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 27, 2017 Category: Pharmaceuticals Source Type: news

USFDA accepts Sun Pharma arm's ophthalmic drug application
Sun Pharma said that post the USFDA approval, OTX-101 will be commercialised in the US by Sun Ophthalmics, the branded ophthalmics division of Sun Pharma. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 27, 2017 Category: Pharmaceuticals Source Type: news

Government's medicare drive pinches pharma, private hospitals in 2017
Summing up 2017, Indian Pharmaceutical Alliance (IPA) Secretary General D G Shah said that the industry was never up against so many challenges in one single year before. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 27, 2017 Category: Pharmaceuticals Source Type: news

Dr.Reddy's launches anti-cancer injection in US market
The drug, which is used to treat certain types of cancer, was earlier approved by the US Food and Drug Administration (USFDA), DRL said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 26, 2017 Category: Pharmaceuticals Source Type: news

Rhizen receives USFDA orphan drug designation for cancer drug
The USFDA has granted orphan drug designation for Tenalisib (RP6530)... for the treatment of patients with peripheral T-cell lymphoma (PTCL), Alembic Pharmaceuticals said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 26, 2017 Category: Pharmaceuticals Source Type: news

Fooya! founder in patent war over digital vaccine with US Pharma giant
Moderna has filed for the 'digital vaccines' trademark and the US Patent and Trademark Office (USPTO) is opening up the case for public comment tomorrow. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 25, 2017 Category: Pharmaceuticals Source Type: news